Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study

álvarez Enric; Bernardo Miguel; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Gutiérrez Casares José Ramón; Hospital Clinic de Barcelona Barcelona; Hospital de la Santa Creu i Sant Pau; Hospital Universitario de Salamanca; IBSantpau Barcelona Spain; Institut dinvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain; Montejo ángel L.; Servicio Extreme?o de Salud Badajoz Spain; Universitat Autónoma de Barcelona Barcelona; University of Salamanca Salamanca Spain

首页> 外文期刊>The European Journal of Psychiatry (Spanish Edition) >Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study

【24h】

Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study

机译：齐普拉西酮与奥氮平治疗精神分裂症相关的体重增加：六个月的双盲随机平行分组研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The European Journal of Psychiatry (Spanish Edition)》 |2012年第4期|共页
作者
álvarez Enric; Bernardo Miguel; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Gutiérrez Casares José Ramón; Hospital Clinic de Barcelona Barcelona; Hospital de la Santa Creu i Sant Pau; Hospital Universitario de Salamanca; IBSantpau Barcelona Spain; Institut dinvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain; Montejo ángel L.; Servicio Extreme?o de Salud Badajoz Spain; Universitat Autónoma de Barcelona Barcelona; University of Salamanca Salamanca Spain;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study [J] . álvarez Enric, Bernardo Miguel, Gutiérrez Casares José Ramón, The European journal of psychiatry. . 2012,第4期

机译：齐普拉西酮与奥氮平治疗精神分裂症相关的体重增加：六个月的双盲随机平行分组研究
2. Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. [J] . Harvey PD, Bowie CR, Loebel A The Journal of neuropsychiatry and clinical neurosciences . 2006,第1期

机译：长期非典型抗精神病药物治疗使神经心理学正常化：齐拉西酮与奥氮平的六个月随机，双盲比较结果。
3. Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. [J] . Harvey PD, Siu CO, Romano S Psychopharmacology . 2004,第3期

机译：齐拉西酮与奥氮平在患有精神分裂症或精神分裂症的急性疾病患者中的认知作用的随机，对照，双盲，多中心比较。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder. [D] . Cha, Danielle Soh-Young. 2016

机译：一项随机，双盲，安慰剂对照的交叉试验评估了鼻内胰岛素对难治性重度抑郁症患者认知和情绪加工的影响。
6. Double-blind randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder [O] . Walter Deberdt, Ilya Lipkovich, Alexandra N Heinloth, 2008

机译：一项双盲随机试验比较了继续使用奥氮平与改用喹硫平在超重或肥胖的精神分裂症或精神分裂症患者中的疗效和安全性
7. Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder [O] . Deberdt, Walter, Lipkovich, Ilya, Heinloth, Alexandra N, 2008

机译：一项双盲，随机试验，比较了继续使用奥氮平与改用喹硫平在超重或肥胖的精神分裂症或精神分裂症患者中的疗效和安全性

Ziprasidone versus Olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study

著录项

相似文献

相关主题

期刊订阅